BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 20673632)

  • 1. Efficient synthesis and biological evaluation of demethyl geranylgeranoic acid derivatives.
    Wada A; Wang F; Suhara Y; Yamano Y; Okitsu T; Nakagawa K; Okano T
    Bioorg Med Chem; 2010 Aug; 18(16):5795-806. PubMed ID: 20673632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and biological activity of 13-substituted retinoic acids.
    Wada A; Fukunaga K; Ito M; Mizuguchi Y; Nakagawa K; Okano T
    Bioorg Med Chem; 2004 Jul; 12(14):3931-42. PubMed ID: 15210160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoid agonist activities of synthetic geranyl geranoic acid derivatives.
    Araki H; Shidoji Y; Yamada Y; Moriwaki H; Muto Y
    Biochem Biophys Res Commun; 1995 Apr; 209(1):66-72. PubMed ID: 7726866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis in human hepatoma cell line induced by 4,5-didehydro geranylgeranoic acid (acyclic retinoid) via down-regulation of transforming growth factor-alpha.
    Nakamura N; Shidoji Y; Moriwaki H; Muto Y
    Biochem Biophys Res Commun; 1996 Feb; 219(1):100-4. PubMed ID: 8619789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid.
    Beard RL; Colon DF; Song TK; Davies PJ; Kochhar DM; Chandraratna RA
    J Med Chem; 1996 Aug; 39(18):3556-63. PubMed ID: 8784454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
    Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
    J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and biological evaluation of 5-substituted retinoic acids.
    Wada A; Matsuura N; Mizuguchi Y; Nakagawa K; Ito M; Okano T
    Bioorg Med Chem; 2008 Sep; 16(18):8471-81. PubMed ID: 18760926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of lipid droplets induced by 2,3-dihydrogeranylgeranoic acid distinct from geranylgeranoic acid.
    Kodaira Y; Kusumoto T; Takahashi T; Matsumura Y; Miyagi Y; Okamoto K; Shidoji Y; Sagami H
    Acta Biochim Pol; 2007; 54(4):777-82. PubMed ID: 18066407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity.
    Dawson MI; Hobbs PD; Peterson VJ; Leid M; Lange CW; Feng KC; Chen Gq ; Gu J; Li H; Kolluri SK; Zhang Xk ; Zhang Y; Fontana JA
    Cancer Res; 2001 Jun; 61(12):4723-30. PubMed ID: 11406543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses and structure-activity relationships of novel retinoid X receptor agonists.
    Hibi S; Kikuchi K; Yoshimura H; Nagai M; Tai K; Hida T
    J Med Chem; 1998 Aug; 41(17):3245-52. PubMed ID: 9703470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D3- and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells.
    Botling J; Oberg F; Törmä H; Tuohimaa P; Bläuer M; Nilsson K
    Cell Growth Differ; 1996 Sep; 7(9):1239-49. PubMed ID: 8877104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.
    Dhar A; Liu S; Klucik J; Berlin KD; Madler MM; Lu S; Ivey RT; Zacheis D; Brown CW; Nelson EC; Birckbichler PJ; Benbrook DM
    J Med Chem; 1999 Sep; 42(18):3602-14. PubMed ID: 10479291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
    Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation-induced apoptosis and cell surface expression of Fas (CD95) ligand are reciprocally regulated by retinoic acid receptor alpha and gamma and involve nur77 in T cells.
    Tóth R; Szegezdi E; Reichert U; Bernardon JM; Michel S; Ancian P; Kis-Tóth K; Macsári Z; Fésüs L; Szondy Z
    Eur J Immunol; 2001 May; 31(5):1382-91. PubMed ID: 11465095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on retinoids. IV. Design, synthesis and structure-activity relationships of di-t-butylphenyl compounds].
    Guo ZR; Liu QZ; Chu FM; Wang MM; Pi SQ; Yang GZ; Han R; Xia LJ; He XQ
    Yao Xue Xue Bao; 1997 Nov; 32(11):830-43. PubMed ID: 11596202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 9Z-retinoic acid analogs having 2-substituted benzo[b]furan.
    Okitsu T; Nakazawa D; Nakagawa K; Okano T; Wada A
    Chem Pharm Bull (Tokyo); 2010 Mar; 58(3):418-22. PubMed ID: 20190455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
    Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
    J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expression.
    Rosenauer A; Nervi C; Davison K; Lamph WW; Mader S; Miller WH
    Cancer Res; 1998 Nov; 58(22):5110-6. PubMed ID: 9823320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactoferrin interaction with retinoid signaling: cell growth and apoptosis in mammary cells.
    Baumrucker CR; Schanbacher F; Shang Y; Green MH
    Domest Anim Endocrinol; 2006 May; 30(4):289-303. PubMed ID: 16168621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
    Agadir A; Shealy YF; Hill DL; Zhang X
    Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.